A. Ulaş

发表

Assessment of Falls in Older People: Is There any Association Between Restless Leg Syndrome and Falls?

Hilal Özkaya, K. Silay, Ahmet Yalçin, 2016 .

Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?

A. Ulaş, N. Avcı, T. Kos, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Hospitalization risk according to geriatric assessment and laboratory parameters in elderly hematologic cancer patients.

K. Silay, S. Akinci, A. Ulaş, 2015, Asian Pacific journal of cancer prevention : APJCP.

Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology

M. Gumus, K. Aydın, A. Sevinç, 2015, Tumor Biology.

Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

A. Sevinç, A. Ulaş, M. Benekli, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.

U. Demirci, A. Bilici, M. Gumus, 2013, Asian Pacific journal of cancer prevention : APJCP.

Factors Affecting Prognosis in Small Cell Lung Cancer

A. Ulaş, Serdar Karakullukçu, E. Karaman, 2022 .

Selective internal radiation therapy in untreated patients with unresectable liver dominant metastatic colorectal cancer.

N. Zengi̇n, A. Ulaş, B. Yalcin, 2017, Future oncology.

Neutrophil to lymphocyte ratio--not an independent prognostic factor in patients with the myelodysplastic syndrome.

A. Alkan, K. Silay, S. Akinci, 2015, Asian Pacific journal of cancer prevention : APJCP.

An Independent Risk Factor for Quality of Life in Cancer Patients: Urinary Incontinence

K. Silay, S. Akinci, A. Ulaş, 2015 .

Favorable results of patients with pT1a, b, c, lymph node-negative early breast cancer in the long interval

K. Altundag, A. Ulaş, N. Bulut, 2019, Journal of cancer research and therapeutics.

Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey

U. Demirci, A. Bilici, M. Gumus, 2013, Thoracic cancer.

A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer

K. Silay, A. Ulaş, S. Tokluoğlu, 2014, PloS one.

We should not underestimate Vitamin B12 and folic acid deficiencies in oldest old

K. Silay, A. Ulaş, T. Guney, 2014 .

Effect of Covid-19 pandemic on patients undergoing definitive chemoradiotherapy

A. Ulaş, E. Karaman, 2022, Cumhuriyet Medical Journal.

Role of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer in the COVID-19 Pandemic

A. Ulaş, A. Onder, A. Deligonul, 2022, Cureus.

Optimal timing of adjuvant treatment in patients with early breast cancer

F. Onder, A. Ulaş, S. Muallaoğlu, 2011, Medical oncology.

Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

H. Harputluoglu, A. Sevinç, I. Turker, 2012, Oncology Research and Treatment.

Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)

A. Sevinç, I. Oztop, A. Ulaş, 2015, Thoracic cancer.

Expectations of response from octreotide therapy in recurrent phosphaturic mesenchymal tumors--do they reflect reality?

A. Ulaş, B. Yalcin, M. Şendur, 2015, Asian Pacific journal of cancer prevention : APJCP.

The predictive value of epidemiological characteristics, clinical and laboratory findings in adult lymphadenopathy etiology.

K. Silay, A. Ulaş, I. Dilek, 2015, European review for medical and pharmacological sciences.

Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.

A. Bilici, M. Gumus, A. Sevinç, 2013, Asian Pacific journal of cancer prevention : APJCP.

Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology

M. Gumus, H. Kavgacı, D. Aydın, 2016, Tumor Biology.

Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.

U. Demirci, S. Buyukberber, A. Sumbul, 2016, Breast.

Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.

A. Ulaş, N. Avcı, T. Kos, 2015, Asian Pacific journal of cancer prevention : APJCP.

Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival

A. Ulaş, S. Kılıçkap, O. Eşbah, 2014, Journal of gastric cancer.

Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology.

Ali Inal, Abdurrahman Isikdogan, S. Buyukberber, 2012, Asian Pacific journal of cancer prevention : APJCP.

Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.

A. Ulaş, Ş. Tolunay, T. Evrensel, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients

H. Harputluoglu, U. Demirci, A. Sevinç, 2012, Medical Oncology.

Prognostic Factors Affecting Survival In Patients With Operable Non-Small Cell Lung Cancer: Single Center Experience and Review of The Literature

A. Bilici, A. Ulaş, E. Arpacı, 2014 .

Lung cancer in women, a different disease: survival differences by sex in Turkey.

K. Silay, A. Ulaş, S. Tokluoğlu, 2015, Asian Pacific journal of cancer prevention : APJCP.

The relationship between adjuvant chemotherapy and thiol-disulfide compounds

P. Akyol, A. Ulaş, B. Yalcin, 2022, Journal of cancer research and therapeutics.

Are tyrosine kinase inhibitors as effective as they are safe in renal cell cancer patients over the age of 65?

A. Ulaş, F. T. Kos, D. Dede, 2022, Annals of Clinical and Analytical Medicine.

Assessment of Palliative Care in Lung Cancer in Turkey

Y. Erdoğan, G. Cakmak, S. Barış, 2016, Medical Principles and Practice.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)

H. Harputluoglu, A. Sevinç, I. Turker, 2014, Journal of chemotherapy.

Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology

U. Yilmaz, I. Turker, A. Ulaş, 2014, Medical Oncology.

Primary gastric Hodgkin lymphoma and metachronous early gastric carcinoma: a case report

A. Ulaş, S. Tokluoğlu, N. Alkış, 2011, Medical oncology.

Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma.

S. Alıcı, A. Sevinç, C. Camcı, 2012, Asian Pacific journal of cancer prevention : APJCP.

Clinicopathological characteristics and prognosis of patients according to recurrence time after radical nephrectomy for localized renal cell carcinoma: a multicenter study of Anatolian Society of Medical Oncology (ASMO).

U. Demirci, M. Küçüköner, K. Aydın, 2014, Anticancer research.

Occult urinary incontinence in elderly women and its association with geriatric condition.

K. Silay, A. Ulaş, B. Yalcin, 2016, European Review for Medical and Pharmacological Sciences.

Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer.

N. Zengi̇n, A. Ulaş, B. Yalcin, 2015, Future oncology.

Retrospective evaluation of premenopausal hormone‐sensitive breast cancer patients treated with adjuvant gonadotropin‐releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

S. Kaya, A. Ulaş, S. Tokluoğlu, 2018, Asia-Pacific journal of clinical oncology.

Docetaxel and cisplatin in first line treatment of patients with unknown primary cancer: a multicenter study of the Anatolian Society of Medical Oncology.

U. Demirci, S. Buyukberber, A. Ulaş, 2014, Asian Pacific journal of cancer prevention : APJCP.

Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases

A. Bilici, K. Silay, A. Ulaş, 2015, Tumor Biology.

Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab

U. Demirci, M. Gumus, S. Buyukberber, 2013, Oncology Research and Treatment.

Risk factors for stage IV breast cancer at the time of presentation in Turkey.

S. Gunduz, A. Ulaş, S. Gucuk, 2013, Asian Pacific journal of cancer prevention : APJCP.

Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

M. Gumus, I. Oztop, U. Yilmaz, 2012, Oncology.

Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey.

A. Bilici, K. Silay, A. Ulaş, 2015, Asian Pacific journal of cancer prevention : APJCP.

Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial.

O. Yazıcı, A. Ulaş, M. Uysal, 2014, Anticancer research.

The myth of not disclosing the diagnosis of cancer: does it really protect elderly patients from depression?

K. Silay, A. Ulaş, Esin Ozturk, 2015, Asian Pacific journal of cancer prevention : APJCP.

Demographic Characteristics and Treatment Outcomes of Patients with Renal Cell Cancer: Single Center Experience

A. Ulaş, B. Yalcin, B. Bilgin, 2016 .

Lung Carcinoma Developing Afatinib-Associated Skin Reactions

A. Ulaş, E. Karaman, Ayça ADIACAR SEZER, 2023, Journal of Oncological Sciences.

Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer.

N. Zengi̇n, A. Ulaş, B. Yalcin, 2015, Future oncology.

Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.

A. Bilici, M. Gumus, A. Sevinç, 2013, Asian Pacific journal of cancer prevention : APJCP.

Thrombotic thrombocytopenic purpura following salvage chemotherapy with paclitaxel, ifosfamide and cisplatin in a patient with a refractory germ cell tumor: A case report and review of the literature.

K. Silay, A. Ulaş, B. Yalcin, 2015, Oncology letters.

Docetaxel and cisplatin in first line treatment of patients with unknown primary cancer: a multicenter study of the Anatolian Society of Medical Oncology.

U. Demirci, S. Buyukberber, A. Ulaş, 2014, Asian Pacific journal of cancer prevention : APJCP.

The Prognostic Significance Of Inflammation Associated Blood Cell Markers In Metastatic Colorectal Cancer

A. Ulaş, Ahmet Hüsrev Tekeli, 2024, Journal of Bursa Faculty of Medicine.

Substance P is a major mediator causing delayed emesis in anthracycline-based chemotherapy--really?

K. Silay, A. Ulaş, B. Yalcin, 2015, Asian Pacific journal of cancer prevention : APJCP.